{
  "trial_id": "NCT04509362",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Clinical diagnosis of type 1 diabetes >1 year prior to consent date",
      "label": "met",
      "evidence": "investigator's judgment"
    },
    {
      "criterion": "HbA1c < 12.5%",
      "label": "met",
      "evidence": "lab studies"
    },
    {
      "criterion": "Age 7-17 years at the initiation of the system",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Multiple Daily Injections (Basal Bolus therapy) with Total daily insulin use of great than 8.0 units per day over a 1-week period",
      "label": "met",
      "evidence": "patient reports"
    },
    {
      "criterion": "Will be clinically able to start the AHCL system",
      "label": "met",
      "evidence": "patient appears well"
    },
    {
      "criterion": "History of 3 clinic visits in the last year",
      "label": "unknown",
      "evidence": ""
    }
  ],
  "exclusion": [
    {
      "criterion": "DKA in the 6 months prior to screening visit",
      "label": "not_met",
      "evidence": "patient reports no nausea, vomiting, or abdominal discomfort"
    },
    {
      "criterion": "Pregnancy",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Untreated diabetes retinopathy, or other causes that ,in the investigator's opinion, precludes the individual from participating in the trial.",
      "label": "unknown",
      "evidence": ""
    }
  ],
  "notes": "Patient has had previous episodes of diabetic ketoacidosis, but appears well and is not experiencing any symptoms at this time.",
  "_meta": {
    "topic_id": "29",
    "trial_id": "NCT04509362",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}